Lactic Acid Pharmaceutical USP/EP (Pharmacopeial 88-92% 2-Hydroxypropanoic Acid Solution) Storage
Lactic Acid Pharmaceutical USP/EP (Pharmacopeial-Grade 88-92% 2-Hydroxypropanoic Acid Solution) Storage — Compendial Lactic Acid Tank Selection at Pharmaceutical pH-Adjuster, Parenteral-Diluent, Cosmeceutical Chemical-Peel, and Compounding Pharmacy Operations
Lactic Acid Pharmaceutical USP (also called pharmaceutical lactic acid 88%, pharmaceutical lactic acid 90%, 2-hydroxypropanoic acid; CAS 50-21-5; molecular formula C3H6O3; molecular weight 90.08 g/mol; alpha-hydroxy carboxylic acid) is a clear, colorless to pale-yellow, syrupy aqueous solution typically supplied at 88-92% w/w lactic acid + lactide oligomer concentration meeting the USP-43-NF-38 Lactic Acid monograph and Ph. Eur. 11.0 Lactic Acid monograph. The pharmacopeial liquid concentrate is a partially-self-condensed mixture of lactic-acid monomer + lactide oligomer (cyclic dimer) + linear oligomers in equilibrium; the assay specification refers to total lactic-acid equivalent rather than monomer-only content. Compendial pharmaceutical lactic acid specifications: assay 88-92% w/w (calculated as monomer); identification by IR spectrum + specific gravity 1.20-1.21 + refractive index 1.43-1.44; chloride under 0.005%; sulfate under 0.01%; iron under 10 ppm; calcium under 0.1%; readily carbonizable substances (test with concentrated sulfuric acid; lactic acid layer must remain colorless or near-colorless); specific rotation +0.05 to -0.05 degrees (DL-lactic acid is racemic; L-(+)-lactic acid USP is the pure enantiomer for cosmeceutical + chemical-peel applications); arsenic under 1 ppm; heavy metals under 10 ppm; ICH Q3D + Q3C limits.
Pharmaceutical USP lactic acid functions as parenteral pH-adjuster + buffer + chemical-peel active + cosmeceutical anti-aging active + topical antimicrobial across an extensive pharmaceutical and OTC + cosmetic formulation set. Parenteral pH-adjuster + buffer use: IV calcium gluconate is buffered with lactate to enhance solubility + tissue tolerance; lactated Ringer's solution (Hartmann's solution) is the standard balanced electrolyte IV crystalloid containing sodium lactate as physiologic-buffer base equivalent; many parenteral formulations use lactic acid + sodium lactate as pH 4.5-7.0 buffer pair. Chemical-peel active: USP-grade L-(+)-lactic acid is used at 10-50% concentration in dermatologic + cosmeceutical chemical-peel formulations as an alpha-hydroxy acid (AHA) for skin-resurfacing + photoaging + acne treatment + hyperpigmentation + pseudofolliculitis-barbae management. Cosmeceutical anti-aging active at 1-10% in over-the-counter anti-aging products. Topical antimicrobial: lactic acid is included in OTC + Rx topical antibacterial preparations + bacterial-vaginosis treatment (Acigel, Femanol). Physical properties: density 1.20-1.21 g/cm3; specific gravity 1.20-1.21; viscosity 28 cP at 25°C dropping to 7 cP at 50°C; pH 2.4 in 1% aqueous (strong acid by pH; pKa1 = 3.86); non-flammable + non-combustible at 88-92% concentration; melting point of pure lactic acid 18°C (commercial 88-92% solution liquid at room temperature down to about -10°C); boiling point 122°C at 14 mmHg + decomposition above 165°C at atmospheric pressure; fully water-miscible; soluble in ethanol + glycerin + propylene glycol; insoluble in chloroform.
The eight sections below cite USP-NF 43, Ph. Eur. 11.0, JP 18, FDA 21 CFR Parts 210 + 211 + 600-680, USP <791> pH, USP <1116> Microbial Bioburden, ASME BPE-2022, ICH Q3D + Q3C + Q7 + Q9 + Q10, FDA 21 CFR 184.1061 GRAS Lactic Acid, and operating practice at Corbion (Corbion is the global leader in pharmaceutical-grade lactic acid via the Corbion Purac brand at Gorinchem Netherlands + Blair NE U.S. operations), Galactic (Belgium), ADM (Archer Daniels Midland), Cargill, Henan Jindan Lactic Acid Technology (China), and pharmaceutical manufacturing operations at Baxter International (lactated Ringer's), Hospira (Pfizer), B. Braun Medical, ICU Medical, Fresenius Kabi, and cosmeceutical / dermatologic manufacturing at SkinCeuticals (L'Oreal), Obagi Medical (Bausch Health), AlphaScience, NeoStrata (Bristol Myers Squibb / Johnson & Johnson Consumer Health), Alastin Skincare.
1. Material Compatibility Matrix
Pharmaceutical USP lactic acid is a moderately strong organic acid (pKa1 3.86) with no oxidizer character, no halogen species, no sulfur species, and chelating capability with multivalent cations (calcium, iron, magnesium, manganese, copper). Material selection is driven by acid-attack at pH ~0 of the 88-92% concentrate and chelation-attack of iron-bearing materials.
| Material | USP Lactic Acid 88-92% 20-30°C | Heated USP 30-50°C | Notes |
|---|---|---|---|
| HDPE | A | A | Excellent at non-product-contact bulk-receipt + outdoor bulk-feedstock + manufacturer ingredient storage at concentrate; FDA-grade HDPE per 21 CFR 177.1520 standard at pharmaceutical-feedstock service |
| XLPE | A | A | Excellent at heated bulk-receipt + outdoor bulk feedstock with thermal cycling |
| Polypropylene (PP) homopolymer | A | A | Acceptable at injection-molded fittings + filter housings; FDA-grade PP per 21 CFR 177.1520 at pharma-feedstock service |
| Carbon steel (A36 / A516-70) | NR | NR | Severe acid-attack + chelation-attack at concentrate; rapid corrosion + iron-leaching; not specified at pharma lactic acid |
| 304 / 304L stainless | B | C | Some pitting + crevice corrosion at extended concentrate contact + elevated temperature; not preferred at pharma lactic acid |
| 316L stainless electropolished (Ra under 0.5 microns) ASME BPE | A | A | Acceptable at all product-contact lactic acid pharma service at 88-92% concentrate; CIP/SIP-compatible; standard at parenteral-formulation + cosmeceutical-formulation tanks; pitting risk at chloride contamination requires careful CIP-cleaning protocol |
| FRP vinyl ester (Derakane 411) | A | A | Excellent at concentrate; standard at industrial lactic-acid bulk-storage at non-pharmaceutical scale |
| FRP vinyl ester (Derakane 510C-470) | A | A | Premium chlorinated vinyl ester for severe acid + heated service |
| Viton (FKM) | A | A | Standard elastomer at lactic-acid seal + gasket + diaphragm-valve service |
| FFKM (perfluoroelastomer) | A | A | Premium specialty for high-cycle valve and flow-control sealing |
| Platinum-cured silicone (Pt-silicone, ASME BPE) | A | A | Standard product-contact elastomer; USP <87> + <88> Class VI biocompatibility |
| EPDM peroxide-cured (BPE-grade) | A | A | Standard at sanitary diaphragm valves + tri-clamp gaskets at heated CIP/SIP service |
| PTFE / Teflon | A | A | Standard at sanitary flange + valve-seat + diaphragm-valve seal service; USP Class VI grades available |
| PFA (perfluoroalkoxy) | A | A | Premium product-contact piping at high-purity service |
| Glass-lined steel (3.3 borosilicate) | A | A | Standard at API + intermediate reactor service at concentrate; common at heated lactic-acid + cosmeceutical-formulation kettles |
The dominant industrial pattern at pharmaceutical lactic-acid-using manufacturing is HDPE rotomolded tanks at the bulk-receipt warehouse for raw-material drum + tote + bulk-tanker receipt + short-term staging, then transfer through 316L sanitary piping (with careful chloride-contamination control to prevent pitting) or FRP vinyl-ester piping to ASME BPE 316L formulation vessels for product-contact service. Lactic acid at 88-92% concentrate is less corrosively aggressive than mineral acids (HCl, H2SO4, HNO3, HF) but still requires acid-resistant material selection. OneSource Plastics' 5-brand HDPE network covers the bulk-receipt + raw-material-warehouse + cosmeceutical + compounding-pharmacy ingredient-storage envelope.
2. Real-World Industrial Use Cases
Lactated Ringer's Solution (Hartmann's Solution) IV Crystalloid. Sodium lactate (the sodium salt of lactic acid; produced from lactic acid + sodium hydroxide neutralization) is the principal physiologic-buffer base in lactated Ringer's IV crystalloid solution (Baxter International, Hospira / Pfizer, B. Braun Medical, ICU Medical, Fresenius Kabi all manufacture). Lactated Ringer's contains sodium chloride 6.0 g/L, sodium lactate 3.1 g/L, potassium chloride 0.30 g/L, calcium chloride 0.20 g/L per liter at pH 6.0-7.5. Approximately 200-300 million liters of lactated Ringer's are produced annually for IV-fluid hospital + emergency-department + outpatient infusion-center markets globally; a critical USP-grade lactic acid demand center.
Parenteral pH-Adjuster + Buffer Use. USP lactic acid is used at low concentrations as pH-adjusting acid in parenteral formulations requiring slightly acidic pH (pH 4.5-6.0) to maintain solubility + stability of acid-stable APIs. Parenteral calcium gluconate (lactate-stabilized calcium gluconate IV; Hospira / Pfizer + Fresenius Kabi + Sandoz manufacture); IV diluent + buffering for cosmeceutical + dermatologic + opthalmic preparations.
Cosmeceutical Chemical-Peel Active. USP-grade L-(+)-lactic acid is used at 10-50% concentration in physician-administered + medical-grade cosmeceutical chemical-peel formulations as an alpha-hydroxy acid (AHA) for skin-resurfacing + photoaging + acne treatment + hyperpigmentation + keratosis + pseudofolliculitis-barbae management. Iconic chemical-peel + AHA-active products: SkinCeuticals (L'Oreal Active Cosmetics) Glycolic Renewal Cleanser + Lactic-acid Glycolic Renewal Treatment, Obagi Medical Nu-Derm + Skintrinsiq Lactic Acid Peel, NeoStrata (Bristol Myers Squibb / J&J Consumer Health) AHA-line at 5-15% lactic acid, AlphaScience AlphaPeel, Alastin Skincare. Inclusion 5-50% w/v depending on formulation strength + clinical-protocol intent. Manufacturing requires USP-grade L-(+)-lactic acid (the pure enantiomer; not the racemic DL-lactic-acid USP) for clinical safety + efficacy + chirality-specific receptor pharmacology.
OTC + Cosmeceutical Anti-Aging Manufacturing. USP lactic acid at 1-10% concentration is included in OTC anti-aging + skincare + acne-treatment + cosmeceutical preparations: Eucerin Roughness Relief (Beiersdorf, lactic acid + urea), Amlactin Daily Moisturizing Lotion (Sandoz, 12% lactic acid), Sun-Mark / store-brand AmLactin alternatives, anti-acne + anti-keratosis + xerosis preparations. Inclusion 5-15% in dedicated AHA products; 1-3% in combination anti-aging preparations.
Vaginal Health + Bacterial-Vaginosis Manufacturing. USP lactic acid is included in vaginal-health + bacterial-vaginosis treatment + vaginal-pH-restoration OTC products: RepHresh Pro-B Probiotic Capsules + RepHresh Vaginal Gel (Procter & Gamble), Femanol vaginal-gel + Acigel (lactic-acid-based vaginal pH-restoration). Inclusion 0.5-2% lactic acid combined with sodium lactate buffer + propylene glycol + carbomer thickener.
Compounding Pharmacy + Customized-Cosmeceutical Working Stocks. 503A + 503B compounding operations + medical-grade compounding spas + dermatologist-office cosmeceutical-formulation programs stock USP lactic acid in 1-pint to 5-gallon HDPE drums + quart bottles for use in patient-specific topical, vaginal, and chemical-peel compounded preparations under USP <795> non-sterile + USP <797> sterile compounding standards.
Industrial Lactic-Acid Bulk Manufacturing Context. Pharmaceutical USP lactic acid is a small fraction of total lactic-acid production globally; the larger volume is technical-grade industrial lactic acid for food-additive (E270), feed-additive, polylactic-acid (PLA) bioplastic feedstock, and industrial cleaning applications. Pharmaceutical-grade lactic acid is produced at dedicated USP-grade refining lines + lot-controlled production at qualified suppliers (Corbion Purac being the global leader); supplier qualification + USP-grade certification + lot-traceability are critical at pharmaceutical manufacturing.
3. Regulatory Hazard Communication
OSHA HazCom GHS Classification. USP pharmaceutical lactic acid 88-92% concentrate is classified as Skin Corrosive Category 1B (causes severe skin burns + eye damage; pH ~0 of concentrate places it in skin-corrosive range); Eye Damage Category 1 (causes serious eye damage). H-statements: H314 Causes severe skin burns and eye damage. P-statements: P260 Do not breathe mist + vapors; P264 Wash thoroughly after handling; P280 Wear protective gloves + protective clothing + eye protection + face protection; P301+P330+P331 IF SWALLOWED: Rinse mouth + Do NOT induce vomiting; P303+P361+P353 IF ON SKIN: Take off immediately all contaminated clothing + Rinse skin with water; P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes + Remove contact lenses if present; P310 Immediately call a POISON CENTER or doctor. NFPA 704 Diamond: Health 3, Flammability 0, Instability 0. Environmental: rapidly biodegradable; aquatic toxicity moderate (fish LC50 ~50 mg/L).
FDA cGMP Compliance Framework. Pharmaceutical USP lactic acid used in finished drug products is regulated under 21 CFR Part 210 + 211 (finished pharmaceuticals) and 21 CFR Parts 600-680 (biologics). Identity testing per 21 CFR 211.84(d)(2) requires at least one specific identity test on each container received; USP identification by IR spectrum + specific gravity + refractive index + assay + readily-carbonizable substances + specific rotation (for L-(+)-grade specifically) are the standard pharmacopeial identity panel. ICH Q3D + Q3C apply to elemental + residual-solvent impurities. ICH Q5A viral safety considerations apply when lactic acid is sourced from animal-cell-culture fermentation; modern pharmaceutical lactic acid is essentially all microbial-fermentation-derived (corn-glucose feedstock + bacterial fermentation by Lactobacillus + Bacillus species at Corbion + Galactic + ADM + Cargill operations).
USP-NF 43 Compendial Specifications. Pharmacopeial harmonized lactic acid specifications: assay 88-92% w/w lactic acid + lactide oligomer; identification by IR spectrum + specific gravity 1.20-1.21 + refractive index 1.43-1.44 + sensory; chloride under 0.005%; sulfate under 0.01%; iron under 10 ppm; calcium under 0.1%; readily carbonizable substances (sulfuric acid test); specific rotation +0.05 to -0.05 degrees for racemic DL-USP grade; +0.7 to +1.5 degrees for L-(+)-USP grade; arsenic under 1 ppm; heavy metals under 10 ppm; ICH Q3D elemental impurities; ICH Q3C residual solvents.
DOT and Shipping. USP pharmaceutical lactic acid 88-92% concentrate is regulated under 49 CFR DOT Hazardous Materials Regulations: UN3265 Corrosive liquid, acidic, organic, n.o.s. or specifically named UN3253 or similar; Hazard Class 8 Corrosive Liquid; Packing Group II (severe corrosive + eye-damage hazard). Shipped in DOT-spec containers: HDPE drums (5-30-55-gallon), HDPE 275-330-gallon IBC totes (DOT-31HA1/Y rating), and stainless or HDPE-lined tank trucks (DOT 412 spec for corrosive liquid).
EPA Air Regulations. Lactic acid storage tanks not subject to 40 CFR Part 60 NSPS Subpart Kb (vapor pressure under 0.1 psi at 20°C, well below 0.75 psi threshold); not subject to Subpart K, KKK, or similar air regulations. Pharmaceutical manufacturing facilities subject to 40 CFR Part 63 Subpart GGG NESHAP for organic HAPs; lactic acid is not a HAP.
FDA GRAS + Direct Food Additive Status. Lactic acid holds GRAS status per FDA 21 CFR 184.1061 (direct human food additive affirmed GRAS) for use as flavoring agent + pH-control agent + curing/pickling agent + preservative + emulsifier + plasticizer + solvent. EU food-additive authorization E270. USP-grade pharmaceutical lactic acid meets and exceeds food-additive purity requirements.
4. Storage System Specification
Bulk-Receipt and Raw-Material-Warehouse Storage. Pharmaceutical USP lactic acid arrives at the manufacturing facility raw-material warehouse via 1-gallon HDPE jugs, 5-gallon HDPE pails, 30-55-gallon HDPE drums, 275-330-gallon HDPE IBC totes, or stainless or HDPE-lined tank trucks (4500-6500 gallon delivery for bulk pharmaceutical-feedstock movements from Corbion + ADM + Cargill operations). Bulk-tanker deliveries at large pharmaceutical operations (Baxter + Hospira + B. Braun lactated Ringer's manufacturing) transfer to dedicated bulk-receipt storage tanks: HDPE rotomolded vertical 1500-15000-gallon vessels, FDA-grade HDPE-blend per 21 CFR 177.1520 with sanitary 4-inch BSP tank-top fill, 4-inch ANSI bottom flanged outlet, atmospheric vent with corrosion-resistant vent filter, tank-mounted level transmitter, and ambient-temperature handling without tank heating (lactic acid 88-92% viscosity 28 cP at 25°C is comfortably pumpable).
Tank Sizing. Typical bulk-receipt tank sizes: 1500-3000 gallons at compounding pharmacies + boutique-cosmeceutical operations; 5000-10000 gallons at mid-size pharmaceutical / cosmeceutical manufacturing; 15000-30000 gallons (multiple HDPE tanks in parallel manifold) at large-scale lactated Ringer's manufacturing.
Compounding Pharmacy + Cosmeceutical Working-Stock Storage. Compounding pharmacies + 503A + 503B + medical-grade cosmeceutical operations stock USP lactic acid in 1-quart to 1-gallon HDPE bottles at the ingredient warehouse + compounding cleanroom. Bottles + drums + totes receiving uses HDPE-pump dispensing into smaller working stocks. Working-stock turnover is typically 6-24 months for the sealed container.
Product-Contact Formulation Tanks. Active formulation + compounding for finished IV-crystalloid / parenteral-buffered / cosmeceutical / chemical-peel preparations occurs in 316L electropolished sanitary stainless tanks per ASME BPE-2022 with internal surface finish Ra under 0.5 microns, all-welded 316L sanitary tri-clamp transfer piping, BPE diaphragm or ball valves, jacketed temperature control, top-mounted impeller agitation, CIP/SIP capability via hot-water + sanitizer + pH-restoration cycles.
Secondary Containment. Bulk-receipt lactic-acid storage vessels at pharmaceutical operations are placed inside HDPE secondary-containment pans sized to 110% of largest single tank capacity per facility-wide containment best-practice. Lactic acid is not regulated as an EPA oil under SPCC + not a CERCLA hazardous substance; facility-wide containment is best-practice for any acidic bulk-storage given the corrosive + spill-area damage potential.
Inert-Gas Blanketing. Pharmaceutical-grade lactic acid bulk storage at high-end sterile-fill + IV-vehicle operations may include nitrogen blanketing of the tank vapor space to minimize CO2 + atmospheric-moisture absorption + pH drift over long-term storage. Atmospheric venting through corrosion-resistant + acid-mist-tolerant vent filter is the dominant pattern; nitrogen blanketing is an upgrade at high-purity parenteral-vehicle service.
5. Field Handling Reality
Operator PPE. Pharmaceutical operators handling USP lactic acid 88-92% concentrate require corrosive-acid-handling PPE: full-face splash shield (over goggles), heavy-duty acid-resistant rubber or neoprene gloves (extended-cuff), acid-resistant chemical apron + sleeve covers, closed-toe acid-resistant boots, eyewash + safety-shower within 10 seconds + 50 feet per OSHA 29 CFR 1910.151 + ANSI Z358.1 emergency-eyewash + safety-shower standard. Cleanroom-grade gowning over corrosive-acid PPE at sterile + cleanroom operations (rare for lactic-acid concentrate; most lactic-acid bulk-handling is at non-sterile bulk-receipt areas before sanitary-stainless transfer to sterile-fill formulation). No respirator required at standard handling; mist-respirator may be needed at confined-space tank-cleaning + degassing operations.
Microbial Bioburden Control. Lactic acid concentrate at 88-92% pH ~0 is inherently microbicidal + microbiostatic; bacterial + mold growth is essentially impossible in concentrated lactic acid. Diluted lactic acid solutions (under 50% w/v) at higher pH lose this self-preservation; bulk-storage best practice for the concentrate eliminates microbial concerns.
Spill Response. Lactic acid spill response is a strong-acid emergency response: (1) immediately evacuate area + activate facility hazardous-material emergency response + isolate area, (2) PPE-equipped responders deploy acid-neutralizer (sodium bicarbonate, sodium carbonate, or commercial acid-neutralizer powder) to convert lactic acid to non-corrosive sodium lactate while controlling foaming + heat-of-neutralization, (3) collect neutralized residue with absorbent + dispose as facility-specific corrosive-waste profile (or non-RCRA solid waste post-neutralization, depending on facility waste-classification protocol), (4) decontaminate spill area with water flush + verification pH-strip test confirming neutral surface, (5) document spill volume + decontamination + containment integrity for facility deviation + investigation system per 21 CFR 211.192 + EPA CERCLA + state environmental reporting if applicable.
Slip Hazard. Lactic acid concentrate's corrosive character makes spill-area + floor-surface degradation a serious concern; concrete + epoxy floor coatings degrade rapidly at acid concentrate contact. Slip-resistant + acid-resistant floor surfaces + secondary containment + immediate spill cleanup + facility flooring inspection + maintenance program are essential at bulk-receipt staging area.
Skin + Eye Burn Hazard. Lactic acid 88-92% concentrate causes severe skin burns + eye damage on contact; emergency eyewash + safety-shower + acid-burn-first-aid station must be immediately accessible at all bulk-handling operations. Skin contact requires immediate 15-minute water flush + medical evaluation; eye contact requires 15-minute water flush + immediate ophthalmologic evaluation. Burn-first-aid program + occupational-health-monitoring + acid-burn-injury-reporting per OSHA 29 CFR 1904 incident-reporting requirements.
Decontamination of Cross-Contamination Spills. Pharmaceutical manufacturing under 21 CFR 211.42 + 21 CFR 211.46 + 21 CFR 211.67 cleaning + cross-contamination prevention requires documented cleaning of any spill area + adjacent equipment + drains + transfer-piping returning to compendial-clean status. Lactic acid spill at multi-product compounding bench triggers cross-contamination investigation, equipment-cleaning verification, pH-restoration confirmation, and quality-deviation closure before resumption of compounding.
Talk to OneSource Plastics
Listed price covers tank + standard fitting package; LTL freight is quoted separately to your delivery ZIP. Call 866-418-1777, use our freight estimator, or try our chemical tank recommender to narrow material selection.